HIV Infections: all 4,340 studies

Page 6 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)CompletedNCT03368053Phase 1Results posted
• A Single Dose of Pembrolizumab in HIV-Infected PeopleTerminatedNCT03367754Phase 1Results posted
• Computer-based Intervention for Alcohol-using HIV/HCV+ WomenCompletedNCT03362476Not applicableResults posted
• (mo)BETTA Trial in Transwomen for Optimization of ARTTerminatedNCT03348163Phase 4Results posted
• Enhanced Housing Placement AssistanceCompletedNCT03334825Not applicableResults posted
• Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and AdolescentsCompletedNCT03332095Phase 1/2Results posted
• A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African AmericansCompletedNCT03331978Not applicableResults posted
• Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAMCompletedNCT03311945Phase 3Results posted
• HIV Reservoir Reduction With Interleukin-2TerminatedNCT03308786Phase 2Results posted
• Suubi4Her: Combination Intervention for Adolescent Girls Transitioning Into Adulthood in UgandaCompletedNCT03307226Not applicableResults posted
• Packaging PrEP to Prevent HIV Among WWIDCompletedNCT03304912Results posted
• Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected AdultsActive, not recruitingNCT03299049Phase 3Results posted
• Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.CompletedNCT03296553Phase 2Results posted
• Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIVCompletedNCT03294499Results posted
• Positive Health Check Evaluation TrialCompletedNCT03292913Not applicableResults posted
• Triggered Escalating Real-time Adherence (TERA) InterventionCompletedNCT03292432Not applicableResults posted
• Linking Infectious and Narcology Care-Part IICompletedNCT03290391Phase 4Results posted
• Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIVCompletedNCT03289676Phase 1Results posted
• Safety and Immunogenicity of Clade C ALVAC and gp120 HIV VaccineCompletedNCT03284710Phase 1/2Results posted
• Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected WomenCompletedNCT03282799Phase 2Results posted
• Innovations in HIV Testing (TI)CompletedNCT03271424Not applicableResults posted
• Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their PartnersCompletedNCT03271307Not applicableResults posted
• MMF for HIV Reservoir ReductionCompletedNCT03262441Phase 2Results posted
• Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)CompletedNCT03251144Phase 1/2Results posted
• PD-1 Inhibition to Determine CNS Reservoir of HIV-InfectionCompletedNCT03239899Phase 1Results posted
• Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03239483Phase 1Results posted
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
• A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without RitonavirCompletedNCT03234036Phase 1Results posted
• GSK3640254 First Time in Human (FTIH) Study in Healthy VolunteersCompletedNCT03231943Phase 1Results posted
• Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South AfricaCompletedNCT03231358Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of CareCompletedNCT03227861Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
• Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected AdultsCompletedNCT03220724Phase 1Results posted
• ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-AdherenceCompletedNCT03218592Phase 4Results posted
• Life Plans Intervention StudyCompletedNCT03215901Not applicableResults posted
• Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)CompletedNCT03212989Phase 1Results posted
• A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIVCompletedNCT03210701Not applicableResults posted
• Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral TherapyCompletedNCT03208231Phase 1/2Results posted
• The Wise App Trial for Improving Health Outcomes in PLWHCompletedNCT03205982Not applicableResults posted
• Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV InfectionCompletedNCT03205566Phase 4Results posted
• Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ARTTerminatedNCT03198559Phase 1/2Results posted
• Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) SymptomsCompletedNCT03182738Not applicableResults posted
• Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNACompletedNCT03181789Phase 1Results posted
• A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSMCompletedNCT03167606Not applicableResults posted
• Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected WomenActive, not recruitingNCT03164564Phase 3Results posted
• Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy SubjectsCompletedNCT03149848Phase 1Results posted
• Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy TrialCompletedNCT03149757Not applicableResults posted
• Partners-based HIV Treatment for Couples Attending Antenatal CareCompletedNCT03149237Not applicableResults posted
• Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIVCompletedNCT03141060Phase 1/2Results posted
• Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV RiskCompletedNCT03135067Not applicableResults posted
• Get Connected Efficacy TrialCompletedNCT03132415Not applicableResults posted
• Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)CompletedNCT03126370Phase 4Results posted
• iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIVCompletedNCT03123731Not applicableResults posted
• Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult ParticipantsCompletedNCT03122223Phase 1/2Results posted
• Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of DolutegravirCompletedNCT03095638Phase 1Results posted
• AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and GamificationCompletedNCT03090958Not applicableResults posted
• Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and LamivudineCompletedNCT03078556Phase 1Results posted
• Youth Power Action Feasibility Study of Online Support Group Intervention Among Adolescents Living With HIV in NigeriaCompletedNCT03076996Not applicableResults posted
• Traditional Healers as Adherence Partners for Persons Living With HIV in Rural MozambiqueCompletedNCT03076359Not applicableResults posted
• PrEP Implementation for Mothers in Antenatal CareCompletedNCT03070600Phase 4Results posted
• Support for Perinatal Adherence and DepressionCompletedNCT03069417Not applicableResults posted
• Puerto Rico Cuidalos Parent-adolescent ProgramCompletedNCT03063385Not applicableResults posted
• A Mobile Phone Game to Prevent HIV Among Young AfricansCompletedNCT03054051Not applicableResults posted
• Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their InfantsCompletedNCT03048422Phase 3Results posted
• Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected AdultsCompletedNCT03045861Phase 2Results posted
• Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019CompletedNCT03016533Phase 3Results posted
• A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive AdultsCompletedNCT02990325Phase 1/2Results posted
• Body Compartment PK for New HIV Pre-exposure Prophylaxis ModalitiesCompletedNCT02985996Phase 1Results posted
• Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality InterventionCompletedNCT02970136Not applicableResults posted
• Strategies to Improve the HIV Care Continuum Among Key Populations in IndiaCompletedNCT02969915Not applicableResults posted
• Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South AfricaCompletedNCT02968849Phase 2/3Results posted
• Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsActive, not recruitingNCT02951052Phase 3Results posted
• The Effect of Ixazomib on the Latent HIV ReservoirCompletedNCT02946047Phase 1/2Results posted
• Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive ParticipantsActive, not recruitingNCT02938520Phase 3Results posted
• A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV RiskCompletedNCT02929069Not applicableResults posted
• Patient Actor Training to Improve HIV Services for Adolescents in KenyaCompletedNCT02928900Not applicableResults posted
• Digital Star: HIV Prevention for Youth in Mental Health TreatmentCompletedNCT02921841Not applicableResults posted
• Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected AdultsCompletedNCT02919306Phase 1/2Results posted
• Monitoring Pre-exposure Prophylaxis for Young Adult WomenCompletedNCT02915367Not applicableResults posted
• Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected AdultsCompletedNCT02915016Phase 1/2Results posted
• mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)CompletedNCT02897141Not applicableResults posted
• iHIVARNA Clinical Trial in HIV Infected IndividualsTerminatedNCT02888756Phase 2Results posted
• Maraviroc Efficacy for Hepatitis CCompletedNCT02881762Phase 4Results posted
• Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in WomenCompletedNCT02858037Phase 3Results posted
• Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205CompletedNCT02852005Phase 1Results posted
• Autonomic Neuropathy, GI Motility, and Inflammation in HIVCompletedNCT02850276Early Phase 1Results posted
• Romidepsin Plus 3BNC117 Phase 2a StudyCompletedNCT02850016Phase 2Results posted
• Development of a Tailored HIV Prevention Intervention for Young MenCompletedNCT02842060Not applicableResults posted
• Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed DyslipidemiaCompletedNCT02833844Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)CompletedNCT02831764Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)CompletedNCT02831673Phase 3Results posted
• Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantActive, not recruitingNCT02797470Phase 1/2Results posted
• Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor SystemCompletedNCT02797262Not applicableResults posted
• Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected AdultsCompletedNCT02797171Phase 1Results posted
• Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency VirusCompletedNCT02761629Phase 4Results posted
• Smart Linkage-to-HIV Care Via a Smartphone AppCompletedNCT02756949Not applicableResults posted
• A Safety and Immunogenicity Trial of IHV01CompletedNCT02756208Phase 1Results posted
• Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol UseCompletedNCT02744040Not applicableResults posted
• Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsCompletedNCT02741128Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)CompletedNCT02738138Phase 3Results posted

← HIV Infections overview